News & Updates
Filter by Specialty:

Dulaglutide safely controls glucose in T2D with CKD
In patients with type 2 diabetes (T2D) with chronic kidney disease (CKD), once-weekly dosage with dulaglutide achieves adequate glycaemic control along with a reduced decline in estimated glomerular filtration rate (eGFR), reports a recent study.
Dulaglutide safely controls glucose in T2D with CKD
28 Aug 2022
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
Children with Staphylococcus aureus bacteraemia (SAB), a common complication of acute hematogenous osteomyelitis (AHO), are vulnerable to a wide range of illnesses, suggests a study. Thus, classifying its severity may aid in treatment decision-making.
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
27 Aug 2022
Adjuvant sorafenib after RFA boosts survival in recurrent hepatocellular carcinoma
The use of sorafenib as an adjuvant therapy after radiofrequency ablation (RFA) appears to improve survival outcomes in patients with recurrent hepatocellular carcinoma who underwent hepatectomy, according to a study.
Adjuvant sorafenib after RFA boosts survival in recurrent hepatocellular carcinoma
27 Aug 2022
UK Biobank: As hard water levels increase, so does the burden of eczema
Exposure to domestic hard water in high concentrations appears to go with a corresponding increase in the prevalence of eczema in adults, as reported in a UK study.